Use of recombinant angiostatin to prevent retinal neovascularization.
Berns
K I
KI
Department of Molecular Genetics and Microbiology, University of Florida College of Medicine, Gainesville, USA.
Meneses
P
P
Duvoisin
R
R
Laipis
P
P
Hauswirth
W
W
D043168:Angiostatins; D000818:Animals; D000831:Animals, Newborn; D004195:Disease Models, Animal; D006801:Humans; D007231:Infant, Newborn; D051379:Mice; D008810:Mice, Inbred C57BL; D010446:Peptide Fragments / Q000235:genetics / Q000494:pharmacology*; D010957:Plasmids / Q000235:genetics; D010958:Plasminogen / Q000235:genetics / Q000494:pharmacology*; D051381:Rats; D011994:Recombinant Proteins / Q000235:genetics / Q000494:pharmacology; D015861:Retinal Neovascularization / Q000517:prevention & control*; D012178:Retinopathy of Prematurity / Q000517:prevention & control
D010446:Peptide Fragments; D011994:Recombinant Proteins; C402400:recombinant kringle 1-3 (rKI-3) of human plasminogen; D043168:Angiostatins; D010958:Plasminogen